TLDR
- UiPath fell 7.7% on Wednesday, hitting a low of $11.00, down from a prior close of $12.04.
- Volume was unusually low, at 85% below the average session volume.
- Most analysts rate PATH a “Hold” with a consensus price target of $13.80.
- Latest quarterly revenue came in at $418.38 million, up 17.3% year over year, beating estimates.
- Convergence Investment Partners initiated a new $4.4 million position in PATH in Q1.
UiPath (PATH) dropped 7.7% on Wednesday, touching an intraday low of $11.00 before last trading at $11.11. The prior close was $12.04.
What made the move unusual was the volume. Only around 6.4 million shares changed hands — roughly 85% below the average session volume of 41.4 million. That kind of thin trading can make price swings look more dramatic than they might otherwise be.
The stock’s 50-day moving average sits at $11.11, and the 200-day moving average is at $11.75. The market cap stands at approximately $5.50 billion.
Where Analysts Stand
The analyst picture is mostly cautious. Of the 17 analysts covering PATH, 14 rate it a “Hold,” two have a “Buy,” and one has a “Sell.” The consensus price target is $13.80.
Recent moves have not been bullish. BMO Capital Markets cut its target from $14 to $13 with a “market perform” rating. Morgan Stanley trimmed its target from $17 to $15 with an “equal weight.” UBS dropped its target from $13 to $12, keeping a “neutral” rating. Bank of America raised its target slightly from $12 to $13 but kept an “underperform” rating.
Needham remains the most optimistic, reiterating a “buy” with a $15 target.
Recent Earnings Were Actually Solid
The drop comes despite PATH posting a decent quarter in late May. Revenue for the period came in at $418.38 million, well above the analyst estimate of $397.54 million. That represented 17.3% growth year over year.
EPS came in at $0.15, matching consensus. The same quarter last year delivered $0.11 EPS. Net margin was 19.58%, and return on equity was 7.92%.
For the full fiscal year, analysts expect $0.40 EPS.
The stock has a 52-week low of $9.20 and a 52-week high of $19.84 — putting Wednesday’s trading well below where it was at its best point over the past year.
On the institutional side, Convergence Investment Partners initiated a new position in Q1, buying 396,363 shares worth approximately $4.4 million, giving them about a 0.08% stake. Institutional investors collectively own 62.50% of the company.
Several smaller funds also added new positions in Q4, including HighMark Wealth Management, Raleigh Capital Management, and Atlas Capital Advisors, though all at modest values under $40,000.
PATH last traded at $11.11 on Wednesday, with the stock sitting near its 50-day moving average.
Stop guessing and start investing with confidence. KnockoutStocks gives you the AI insights, market intelligence, and stock research you need to spot opportunities, cut through the noise, and make smarter investment decisions — all in one powerful platform.
Sign up today and get 50% OFF full access to our premium stock picks.
Simply use coupon code SPECIAL50 at checkout to claim your exclusive discount.
Be the first to comment